News Sentiment

APYX sentiment intelligence

Apyx Medical Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 63 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 4.38 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 63

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+1.9% over one week, -6.6% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction 1.9% Price digesting
Trend fit Trend active -6.6% over four weeks
Fair value 80.1% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 16
Neutral 45
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 63
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 23
Stock Titan 16
TradingKey 6
GlobeNewswire 3
Finviz 2
simplywall.st 2
StockStory 2
MT Newswires 1

Event Lens

What the news is about

Classified themes
Market update 32
Earnings 20
Analyst action 3
Macro sensitivity 3
Regulatory and legal 2
Guidance 2
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 63
GuruFocus Direct company coverage

APYX Initiates Coverage On by HC Wainwright & Co. -- Price Targe

HC Wainwright & Co. has initiated coverage on Apyx Medical (APYX) with a 'Buy' rating and a price target of $7.00. Despite this positive analyst outlook, GuruFocus assesses APYX as significantly overvalued at $4.41 versus its GF Value™ of $2.17. The company's GF Score™ of 65/100

Tone
Positive 71/100
Event
Analyst action
Published
13 Jul 2026 11:10
Source
GuruFocus
Stock Titan Direct company coverage

Apyx Medical (APYX) director nets 6,976 shares from 12,000-option exercise and share withholding

Apyx Medical director Lawrence Waldman reported a net exercise of 12,000 stock options through a Spousal Lifetime Access Trust, resulting in 6,976 net shares issued to him. The options, with an exercise price of $1.88 per share, involved the withholding of 5,024 shares valued at

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 20:39
Source
Stock Titan
Finviz Direct company coverage

APYX - Apyx Medical Corp Volatility & Greeks

This article provides a detailed financial overview of Apyx Medical Corp (APYX), including its latest stock performance, volatility, key financial ratios, and institutional and insider ownership. It highlights various metrics such as market capitalization, sales, EPS, price perfo

Tone
Negative 34/100
Event
Earnings
Published
02 Jul 2026 17:39
Source
Finviz
Stock Titan Direct company coverage

Apyx Medical (NASDAQ: APYX) details 2026 votes on directors, pay and new incentive plan

Apyx Medical is seeking stockholder votes for its 2026 Annual Meeting on August 6, 2026, covering the election of five directors, ratification of RSM US LLP as auditor, a non-binding say-on-pay resolution, and the approval of a new 2026 Share Incentive Plan. The proxy statement d

Tone
Neutral 50/100
Event
Regulatory and legal
Published
26 Jun 2026 20:39
Source
Stock Titan
TradingKey Direct company coverage

Apyx Medical Corp (APYX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Apyx Medical Corp (APYX), detailing its price momentum score of 7.05 and current trading position between resistance at $4.92 and support at $3.59. It lists various technical indicators (MACD, RSI, KDJ, etc.) and moving averages, offe

Tone
Positive 60/100
Event
Market update
Published
25 Jun 2026 06:11
Source
TradingKey
Market source Direct company coverage

Apyx Medical Corporation (APYX): a High Growth Micro-Cap Stock Improving Cellulite and Skin laxity

Apyx Medical Corporation announced new clinical data showing a promising approach to treating cellulite and skin laxity using a combination of Avéli and Renuvion. The study found that 81.8% of patients showed improvement in cellulite with measurable reductions in dimple volume. A

Tone
Positive 72/100
Event
Market update
Published
19 Jun 2026 18:40
Source
Market source
TradingKey Direct company coverage

Apyx Medical Corp (APYX) Earnings Forecast: Future EPS & Revenue Growth Estimates

Apyx Medical Corp (APYX) has an earnings forecast score of 8.40, placing it 35th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $5.00, with a consensus "Buy" rating based on four analysts. The company's expected revenue for the next

Tone
Positive 72/100
Event
Earnings
Published
19 Jun 2026 18:10
Source
TradingKey
TradingKey Direct company coverage

Apyx Medical Corp (APYX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Apyx Medical Corp's (APYX) dividend and stock split history. It notes that no dividends have been distributed over the past five years and there is no data available for historical stock splits. The page also displays current stock trading inf

Tone
Neutral 50/100
Event
Capital return
Published
19 Jun 2026 01:15
Source
TradingKey
TradingKey Direct company coverage

Apyx Medical Corp (APYX) Valuation: PE, PB & Fair Value Analysis

Apyx Medical Corp (APYX) currently holds a valuation score of 9.19, placing it 39th among 204 companies in the Healthcare Equipment & Supplies industry. The company's P/E ratio is -19.21, significantly below its recent high but above its recent low. Key valuation metrics like P/B

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 02:09
Source
TradingKey
TradingKey Direct company coverage

Apyx Medical Corp (APYX) Institutional Confidence

Apyx Medical Corp (APYX) has an institutional shareholding score of 3.00, placing it 132nd out of 204 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 46.73%, showing a slight quarter-over-quarter decrease. Bill Nygren of OAKMX

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 01:09
Source
TradingKey
Stock Titan Direct company coverage

Apyx Medical (NASDAQ: APYX) COO nets 4,467 shares after option exercise

Apyx Medical's Chief Operating Officer, Shawn David Roman, exercised 15,000 stock options at $3.23 per share through The Roman Family Revocable Trust. A net total of 4,467 shares were issued to the trust after 10,533 shares were withheld by the issuer to cover the exercise price

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 21:40
Source
Stock Titan
Stock Titan Direct company coverage

Apyx Medical (NASDAQ: APYX) adds Executive Chairman, awards 450,000 RSUs

Apyx Medical Corporation has appointed Stavros Vizirgianakis, its Board Chairman, as Executive Chairman. In this new role, he will provide strategic leadership, governance oversight, and support for corporate and investor initiatives. In conjunction with this appointment, the com

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 19:40
Source
Stock Titan
Stock Titan Direct company coverage

Apyx Medical (APYX) CFO awarded 132,066 stock options at $4.65

Apyx Medical Corp's Chief Financial Officer, Matthew C. Hill, was granted 132,066 stock options with an exercise price of $4.65 per share, expiring on June 11, 2036. These options will vest ratably over 36 months, becoming fully exercisable on the third anniversary of the grant d

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 00:09
Source
Stock Titan
Stock Titan Direct company coverage

[Form 4] Apyx Medical Corp Insider Trading Activity

Apyx Medical Corp director Minnie Baylor-Henry received a compensatory stock option grant for 50,000 shares on June 11, 2026. The options have an exercise price of $4.65 per share and will vest ratably over a twelve-month period, becoming fully exercisable on the first anniversar

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 00:09
Source
Stock Titan
Stock Titan Direct company coverage

Apyx Medical (NASDAQ: APYX) director awarded 450,000 restricted stock units

Apyx Medical (NASDAQ: APYX) director Stavros G. Vizirgianakis was granted 450,000 restricted stock units (RSUs) as compensation. The RSUs will vest in three equal tranches: an immediate vesting of 150,000 units on June 11, 2026, followed by two more tranches of 150,000 units each

Tone
Neutral 50/100
Event
Market update
Published
15 Jun 2026 23:09
Source
Stock Titan
Stock Titan Direct company coverage

Apyx Medical (NASDAQ: APYX) CEO awarded 213,948 stock options

Apyx Medical CEO Charles D. Goodwin II was granted 213,948 stock options with an exercise price of $4.65 per share. These options will vest ratably over 36 months, becoming fully exercisable on the third anniversary of the grant date, June 11, 2026. This transaction was reported

Tone
Neutral 50/100
Event
Market update
Published
15 Jun 2026 23:09
Source
Stock Titan
Stock Titan Direct company coverage

Apyx Medical (APYX) Sr. VP granted 63,392 stock options at $4.65 strike

Apyx Medical Corp's Sr. V.P. of Operations, Moshe Citronowicz, was granted 63,392 stock options with an exercise price of $4.65 per share, expiring on June 11, 2036. The options will vest ratably over 36 months, becoming fully exercisable on the third anniversary of the grant dat

Tone
Neutral 50/100
Event
Market update
Published
15 Jun 2026 23:09
Source
Stock Titan
Stock Titan Direct company coverage

Apyx Medical (NASDAQ: APYX) director receives 50,000 stock options at $4.65 strike

Apyx Medical Corp director Lawrence Waldman was granted 50,000 stock options as compensation, allowing him to purchase shares at an exercise price of $4.65 per share. These options, expiring on June 11, 2036, will vest ratably over a 12-month period and become fully exercisable o

Tone
Neutral 50/100
Event
Market update
Published
15 Jun 2026 23:09
Source
Stock Titan
Finviz Direct company coverage

APYX - Apyx Medical Corp Stock Price and Quote

This article provides a comprehensive overview of Apyx Medical Corp (APYX) stock, including its current price, financial metrics, analyst ratings, and recent news. It details the company's market performance, key financial figures, and a history of corporate actions and news rele

Tone
Neutral 50/100
Event
Analyst action
Published
04 Jun 2026 10:09
Source
Finviz
Stock Titan Direct company coverage

Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway

Apyx Medical (NASDAQ:APYX) is returning to Miami Swim Week 2026 to showcase its Body by Apyx runway experience, featuring real patients who have undergone Renuvion® and AYON Body Contouring System™ transformations. The event highlights the company's AYON system, which integrates

Tone
Positive 73/100
Event
Market update
Published
27 May 2026 13:38
Source
Stock Titan